Pasar al contenido principal

E2F4DN como agente geroterapéutico para el envejecimiento cerebral (GeroE2F4DN)

PLEC2022-009385

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i en Líneas Estratégicas
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

When the Stars Misfire: Astrocytic Dysfunctions in Major Depressive Disorder

  • González-Arias, Candela
  • Perea, Gertrudis
Major depressive disorder (MDD) is a global public health concern and the leading cause of disability worldwide. It severely impairs cognitive, emotional, and social functioning, and is associated with attention, memory, and executive function deficits. MDD was traditionally considered as a neuropsychiatric disorder focused on neuronal dysfunction; however, growing evidence recognizes glial cells, particularly astrocytes, as crucial cells for the pathophysiology and pathogenesis of MDD. Astrocytes play essential roles in the central nervous system, including neurotransmitter uptake, metabolic support, neurotrophic factor production, and synaptic regulation. Evidence from MDD human patients, as well as studies involving animal models have revealed the astrocytic dysfunction as a critical factor in the pathophysiology of MDD, pointing to widespread alterations in astrocyte density, morphology, and function. This review summarizes current knowledge regarding astrocytes and MDD and discuss the potential of targeting astrocytes as a novel avenue for antidepressant development., We are grateful for critical reading to A. SánchezRuiz and A. Prosilis from Perea lab. This work was supported by the Spanish Ministerio de Ciencia e Innovación y Universidades (MICIU) #PID2022-142617NB-I00 and #PLEC2022-009385 MICIU/AEI/10.13039/501100011033 and by “ERDF A way of making Europe” to G.P.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

When the Stars Misfire: Astrocytic Dysfunctions in Major Depressive Disorder

  • González-Arias, Candela
  • Perea, Gertrudis
Major depressive disorder (MDD) is a global public health concern and the leading cause of disability worldwide. It severely impairs cognitive, emotional, and social functioning, and is associated with attention, memory, and executive function deficits. MDD was traditionally considered as a neuropsychiatric disorder focused on neuronal dysfunction; however, growing evidence recognizes glial cells, particularly astrocytes, as crucial cells for the pathophysiology and pathogenesis of MDD. Astrocytes play essential roles in the central nervous system, including neurotransmitter uptake, metabolic support, neurotrophic factor production, and synaptic regulation. Evidence from MDD human patients, as well as studies involving animal models have revealed the astrocytic dysfunction as a critical factor in the pathophysiology of MDD, pointing to widespread alterations in astrocyte density, morphology, and function. This review summarizes current knowledge regarding astrocytes and MDD and discuss the potential of targeting astrocytes as a novel avenue for antidepressant development., We are grateful for critical reading to A. SánchezRuiz and A. Prosilis from Perea lab. This work was supported by the Spanish Ministerio de Ciencia e Innovación y Universidades (MICIU) #PID2022-142617NB-I00 and #PLEC2022-009385 MICIU/AEI/ 10.13039/501100011033 and by “ERDF A way of making Europe” to G.P., Peer reviewed